Skip to content

Please find below the programme

EAHP BOOST is being accredited by the European Council for Pharmacy Education Accreditation (ECPhA) for a maximum of 8 ECPEC. BOOST participants need to attend all sessions and workshops (except the non-ECPhA accredited session as stated in the programme) to receive their ECPhA accreditation certificate. 

EAHP confirms that the Speakers and the Scientific Committee members responsible for the development of the BOOST programme have signed and submitted the Conflict of Interest Disclosure forms. * Indicates speaker or SC member has stated a conflict of interest which has been reviewed and accepted. See speakers’ bios page for more information. A downloadable PDF version of the Programme will be available shortly. You can find here the FAQs for BOOST. 

Industry sponsored satellites WAIVER

EthicalMedTech: COMPLIANT (EMT-25-04825)

The programme is subject to modification

Friday, 14 November 2025

Date/TimeMeeting/EventRoom
09.00Registration opensMain Entrance
10.00Exhibition opensExhibition Hall
11.00 – 12.00SIG Session: One language for all pharmacy robots – How interoperability can help tackle medicine shortages
Speaker: Patrick Koch, Peka Consulting
South Hall 2
12.00 – 13.00Lunch & Networking – Attended Selected PostersExhibition Hall
13.00 – 13.15Welcome & OpeningSouth Hall 2
13.15 – 14.00

Keynote 1: The synergy of the European and the national systems in managing medicinal product shortages
Speaker: Domenico Di Giorgio, AIFA – Agenzia Italiana del Farmaco

South Hall 2
14.00 – 15.00EU-level intervention to fight critical shortages of medicines – lessons learned and challenges ahead 
Speaker: Matthias Blaas, European Court of Auditors
ECPhA non-accredited activity

South Hall 2
15:00 – 16:00Coffee BreakExhibition Hall
16.00 – 16.45Overview: Compounding in times of shortages – From API to critical medicine in Europe
Speakers:
Théo Henriet, EDQM – European Directorate for the Quality of Medicines & HealthCare
Maggie Saykali, CEFIC – The European Chemical Industry Council, AISBL
South Hall 2
16.30Exhibition closesExhibition Hall
17.00 – 18.30

Workshops

 
 
  • Access to information/information sharing (including logistics) – Hanna Tolonen & Despoina Makridaki (main stakeholders)
  • Medical devices – Louis Bertin & Clara Jolly (main stakeholders)
South Hall 2
 
  • Clinical impact – Inese Sviestina (main stakeholder)
  • Compounding – Håvard Kirkevold (main stakeholder)
Terrace 2B
   

Saturday, 15 November 2025

Date/TimeMeeting/EventRoom
07.00Registration opensMain Entrance
07.00Exhibition opensExhibition Hall
08.00 – 08.45

Overview: Downstream response to medicine shortages: How better coordination can mitigate the effects
Speakers:
Kasper Ernest, GIRP – European Healthcare Distribution Association
Henna Ruutiainen, HUS – Helsinki University Hospital

South Hall 2
09.00 – 09.30Industry Satellite Session
phi Pharma International –
Named-Patient Imports: bridging medicine shortages
Speakers: Audrey Djapni, Susanne Messer, Frank Messer
ECPhA non-accredited activity
South Hall 2
09.30 – 10.30Coffee Break Exhibition Hall
10.30 – 12.00

Workshops

 
 
  • Access to information/information sharing (including logistics) – Hanna Tolonen & Despoina Makridaki (main stakeholder)
  • Medical devices – Louis Bertin & Clara Jolly (main stakeholders)
South Hall 2
 
  • Clinical impact – Inese Sviestina (main stakeholder)
  • Compounding – Håvard Kirkevold (main stakeholder)
Terrace 2B
 Wrap up session & Keynote 
12.00 – 12.45

Keynote 2: Value of real-world evidence in managing medicinal product shortages
Speaker: Monica Dias, EMA – European Medicines Agency

South Hall 2
12.45 – 13.45Interactive Workshop Panel & Wrap up session
Speakers:
Nenad Milljković, EAHP President
Thomas De Rijdt,
EAHP Scientific Committee Chairman
South Hall 2
13.45 – 14.00ClosingSouth Hall 2
14.00Exhibition closesExhibition Hall